|
|
|
|
|
we are looking back on this year's Annual Meeting in Rome, filled with inspiring discussions and exciting new projects. We are looking forward to meeting you again next year!
|
And as always you will find information on our upcoming webinars and further events. Enjoy reading!
|
Best wishes, The ERN-RND Coordination team
|
|
|
|
CONTENT
|
About us Disease Knowledge ERN-RND Webinars Cross-border Healthcare European Blueprint for Rare Diseases Webinar on Neuromodulation for Pediatric Movement Disorders JARDIN Newsletter Upcoming Events
|
|
|
|
ABOUT US
|
|
|
ERN-RND Annual Meeting 2026 in Rome
|
This year’s Annual Meeting took place from October 8–10 in Rome, hosted by our expert center Bambino Gesù Children’s Hospital. Clinicians and patient representatives came together for disease and working group sessions to reflect on achievements, exchange ideas and plan future initiatives.
|
Beyond the meetings, our members enjoyed a visit to the Basilica Papale di San Paolo and a Poster Session featuring a puzzle about ERN-RND activities, with answers hidden in the posters.
|
A big thank you to all participants, speakers and our hosts at Bambino Gesù Children’s Hospital for making this meeting such a success!
|
|
Looking ahead: From July 1–3 next year, we will meet in Brussels for a joint conference with the ERNs EURO-NMD and EPICARE. We look forward to seeing you there!
|
|
|
|
DISEASE KNOWLEDGE
|
|
|
|
|
|
NEW Standard Operating Procedure of Nerve Conduction Studies in patients with LD and suspected peripheral nerve involvement
|
We have a new care standard document for leukodystrophies: SOP of Nerve Conduction Studies for patients with LD and suspected peripheral nerve involvement.
|
|
The document is available in English, further languages will follow soon.
|
|
|
|
ERN-RND WEBINARS
|
|
Upcoming Joint Educational Webinars
|
|
ERN-RND provides free educational webinars on rare neurological and neuromuscular diseases - in collaboration with the European Reference Network for Rare Neuromuscular Diseases (EURO-NMD) and the European Academy of Neurology (EAN). The goal is to share knowledge on rare neurological, movement and neuromuscular disorders via a series of webinars presented by expert members of both networks.
|
|
|
|
|
Next ERN-RND webinar will be on:
|
|
|
17.11.2026, 3-4 pm CET | ‘DBS in GNAO1‘ by Katerina Bernardi. SIGN UP here. (ERN-RND)
|
19.01.2027, 3-4 pm CET | ‘Data Sharing and Quality of Data‘ by Judit Molnar. SIGN UP here. (ERN-RND)
|
|
26.01.2026, 3-4 pm CET | ‘Efficacy of Deep Brain Stimulation for the Treatment of Monogenic Dystonias’ by Sylvia Bösch, Medical University Innsbruck, Austria. SIGN UP here. (ERN-RND)
|
|
|
|
|
|
|
eanCampus offers monthly webinars, 2 master classes per year and weekly podcasts on 3 expert levels (basic, advanced, expert), in total more than 1000 pieces.
|
26 November 2026, 18-19:30 CET | ‘Advancing CIDP Care: Integrating Targeted Therapies, Real-World Evidence and Emerging Biomarkers into Clinical Practice’ by Krista Kuitwaard, Nicolas Dubuisson, Luis Querol. More information here.
|
17 December 2026, 17-18 CET | ‘Digital Health in Clinical Neurosciences’ by Peter Bram’t Hoen, Damiano Mistri, Sefa Ozturk. More information here.
|
|
tba December 2026, CET | ‘Personalised care in Myasthenia Gravis from accurate diagnosis to targeted therapies’. More information here.
|
|
|
|
|
|
|
|
Free Courses for Healthcare Professionals, Caregivers & Family Members
|
The Huntington Academy is a multinational, multilingual initiative designed to address the significant gaps in care provision for families impacted by Huntington’s disease (HD). Its mission is to empower the HD community through knowledge, skills, and collaborative learning, fostering improved care, advocacy, and quality of life.
|
It is an innovative and comprehensive e-learning platform designed to provide accessible and high-quality educational resources for both formal (healthcare professionals) and informal (family members and friends) caregivers of individuals affected by HD. The Huntington Academy contents are available in four languages – Bulgarian, English, French and Spanish.
|
The platform includes two transversal core courses — “What is HD? (HD basics)” and “Communication Skills in HD Care” — and seven domain-specific courses covering key disciplines in HD care (Neurology, Psychology, Nutrition, Physiotherapy, Speech Therapy, Occupational Therapy and Oral Care).
|
|
All the Huntington Academy contents were jointly created by patient organizations, family members and healthcare professionals from the countries involved in the consortium.
|
|
|
|
|
|
CROSS-BORDER HEALTH CARE
|
|
|
|
|
MLD Treatment Eligibility Panel
|
|
In cooperation with the MLD initiative, ERN-RND established a standard pathway for consulting an international MLD expert panel whenever possible benefits of treatment with hematopoietic stem cell transplantation or gene therapy are not straightforward for a patient with confirmed MLD diagnosis. Upon submission of an eligible case, the treatment eligibility panel is convened on an ad hoc basis, organized and supported by the ERN-RND CPMS helpdesk.
|
We encourage all physicians in Europe to discuss the possible benefits of treatment options for difficult cases with this MLD expert panel.
|
You would like to discuss one of your patients with the panel?
|
|
|
|
|
|
Online Multidisciplinary Board for Deep Brain Stimulation in Dystonia
|
ERN-RND has established a standard pathway for providing multidisciplinary expert recommendations concerning Deep Brain Stimulation (DBS) in Dystonia.
Potential questions which the multidisciplinary board may address include (but are not limited to):
|
- INDICATION DBS candidate yes/no?
- TARGET Which Target; GPi, STN, VoA?
- PROGRAMMING Treatment advices of implanted patients
|
To make use of this opportunity, relevant medical data must be provided via the telemedicine platform CPMS beforehand.
|
|
Advice will be provided by at minimum one dystonia expert specialized in DBS and a stereotactic surgeon specialized in DBS, plus further specialists invited case-by-case in a virtual meeting with the referring clinician.
|
|
|
|
Neuroradiology Expert Advice for Diagnostic and Management Decisions in RND
|
ERN-RND has established a standard pathway for providing expert neuroradiological advice across sites. Our ERN-RND member hospitals (and affiliated partners) are encouraged to contact us for any RND case for which they would like a second opinion as a basis for individual recommendations for diagnostic and management strategies to optimize patient care.
|
Possible scenarios for which clinicians might want to use this offer include (but are not limited to):
|
- Child with mild developmental delay: benign / onset of disease? -> cMRI: delayed brain maturation vs. (subtle) structural abnormalities
- Child with delay + subtle signs: acquired / genetic? -> cMRI: acquired disease, e.g. CMV infection / TORCH vs. likely genetic
- Acutely ill patients with suspected encephalopathy -> cMRI: secondary, e.g. infectious / para-infectious vs. metabolic / genetic
- Cerebellar syndrome with fast progression -> cMRI: secondary, e.g., cerebellitis vs. genetic
- Patient after pharmacological treatment showing brain volume reduction -> cMRI: side effects vs. neurodegenerative / neurogenetic disease
To make use of this opportunity, imaging data must be provided via CPMS. Advice will be provided in a virtual meeting between the referring physician plus the initial neuroradiologist and a dedicated ERN-RND neuroradiological expert clinician (and further experts if necessary. Meetings are facilitated by the ERN-RND CPMS helpdesk.
|
You are affiliated to an ERN-RND expert center and would like to receive neuroradiology advice for one of your patients? Please contact us.
|
|
Learn more about the Neuroradiology Expert Advice Panel in this video interview with Eva Bültmann, who is an expert in neuroradiology and coordinates this panel.
|
|
|
|
|
|
EURORDIS: European Blueprint for Rare Diseases EURORDIS has launched the European Blueprint for Rare Diseases, setting out the rare disease community’s proposals for the structure, priorities and delivery of a future EU Action Plan on Rare Diseases. The proposed plan would connect existing initiatives, close remaining gaps and strengthen delivery across Europe.
|
Developed and co-created over ten months, the Blueprint brought together people living with rare diseases and patient organisations, clinicians, researchers, public authorities and industry to develop a shared vision for an EU Action Plan on Rare Diseases. The process included a Core Group of 36 experts, a survey with 236 responses from 33 countries, and a workshop with more than 150 participants in Prague. The proposed EU Action Plan would strengthen national plans and strategies while respecting Member States’ competences and embedding meaningful patient partnership throughout.
|
|
|
|
|
|
JARDIN Newsletter #5 is out
|
|
In this fifth edition of the External Newsletter, you will find highlights from recent achievements, ongoing activities, and key developments across the JARDIN Work Packages, Member States and European Reference Networks (ERNs). This issue also reflects the spirit of cooperation and knowledge exchange that has characterised the Joint Action from the outset, while looking ahead to the activities still to come.
|
|
|
|
|
|
41st SENEP Webinar: Neuromodulation in Pediatric Movement Disorders
|
On the 41st webinar of the SENEP Movement Disorders Working Group on November 18th, Kathryn Yang from Boston Children's Hospital will speak about neuromodulation in pediatric movement disorders and will focus on current applications, indications and outcomes and give some future perspectives.
|
|
To register please click here.
|
|
|
|
UPCOMING EVENTS
|
|
|
|
|
ICAR 2026 November 10-13, 2026, Atlanta, Georgia (USA)
|
ICAR 2026 will take place at the Renaissance Atlanta Waverly Hotel & Convention Center in Atlanta, Georgia, U.S. Please save the date for November 10-13, 2026.
|
ICAR 2026 will be the place to share the latest ataxia research, including updates on Friedreich's ataxia and SCAs 1, 2, 3, 6, 7, and more. Attendees will hear developments in novel treatment approaches, clinical trial results, and scientific debates from leading ataxia researchers. There will also be the opportunity to network with academic and industry leaders. Special sessions and events are planned for junior researchers.
|
|
|
|
|
|
|
1st European Network Conference on Chromatinopathies November 26-28, 2026, Izmir, Türkiye
|
Over two and a half days in İzmir, clinicians, researchers and patient advocates from across Europe come together to establish the first European network dedicated to chromatinopathies — rare genetic disorders caused by changes in the genes that regulate chromatin structure and gene activity.
|
|
Find the programme here. To register click here.
|
|
|
|
|
|
Movement Disorders in Children associated with Neurodegeneration
|
|
February 11-12, 2027, Barcelona, Spain, and online
|
This international meeting will bring together leading experts in paediatric movement disorders, neurodegeneration, genetics and translational neuroscience, with a particular focus on bridging clinical phenotypes, disease mechanisms and emerging therapies.
|
The scientific programme will address key topics including:
|
- Clinical recognition of paediatric neurodegeneration: movement disorders, red flags and disease trajectories
- Molecular diagnosis and disease mechanisms: genomics, multi-omics, mitochondrial and basal ganglia pathways
- Neurodevelopmental, epileptic and treatable metabolic disorders with progressive movement abnormalities
- Biomarkers and trial readiness: neurofilament, transcriptomics, neuroimaging and digital biomarkers
- Precision therapies and advanced interventions: gene therapy, neuroinflammation-targeted treatments, DBS and collaborative networks
|
|
|
|
|
|
|
|
9th RE(ACT) Congress March 10-12, 2027, Budapest, Hungary
|
Since its launch in 2012, RE(ACT) has promoted scientific exchange and encouraged collaboration in rare and orphan diseases. Working with stakeholders in the rare disease community, RE(ACT) demonstrates a shared commitment to overcoming challenges through collective effort, open collaboration, and knowledge sharing.
|
The Congress brings together international leaders, renowned experts, and emerging talents from across disciplines to share breakthrough results, challenge ideas, and help shape the research and policy landscape that will accelerate progress in rare diseases.
To register click here.
|
|
|
|
|
|
|
|
17th European Paediatric Neurology Society Congress
|
|
April 06-10, 2027, Barcelona, Spain
|
Registration is now open for the 2027 EPNS Congress, taking place on the 6-10 April 2027 in Barcelona, Spain. The congress brings together paediatric neurologists and allied professionals from across Europe and beyond for a comprehensive programme of scientific sessions, workshops, and networking opportunities covering the latest developments in paediatric neurology.
|
|
|
|
|
|
|
13th Congress of the European Academy of Neurology
|
|
June 12-15, 2026, Gothenburg, Sweden
|
EAN 2027 will be about exploring the frontiers of treatment in neurology with the Overarching Theme Transforming Neurology: Embracing Every Brain. Where once treatment options for many neurological disorders were limited to supportive care, advances in neuroscience have driven our discipline forward into an era of expanding therapeutic possibilities. Innovations in genetics, immunology, neuroprotection, and precision medicine look set to lead the way to increasing progress in the shape of disease-modifying therapies personalised interventions, and integrated digital health approaches. This exciting realm of discovery and improvement in neurological care will form the basis for a selection of invited lectures and sessions at the congress, including one Symposium and two Focused Workshops.
|
|
|
|
|
|
NEWSLETTER
|
|
The ERN-RND Newsletter is published monthly. Please forward this newsletter to your colleagues who can also sign up to receive it directly here or by emailing communication@ern-rnd.eu
|
|
|
|
Thank you for your support and take care.
|
|
ERN-RND Coordination team
|
|
|
|
|
|
|
|
|